Food and Drug Administration Drug Safety Podcast
FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market
- Author: Podcast
- Narrator: Podcast
- Publisher: Podcast
- Duration: 0:03:00
- More information
Informações:
Synopsis
Listen to an audio podcast of the February 13 2020 FDA Drug Safety Communicationrequesting the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market. Potential risk of cancer outweighs the benefits.
